Source: PRWeb

Press Release: uMed : uMed partners with the Global Parkinson's Genetics Program (GP2) to address emerging research demands in Parkinson's Disease

Genetic samples remotely collected as part of uMed's AccessPD Parkinson's Disease Cohort will contribute to the Global Parkinson's Genetics Program (GP2). Analyses of samples will be linked back to the AccessPD core clinical dataset (combining electronic health record data and patient...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Matt Wilson's photo - Founder & CEO of uMed

Founder & CEO

Matt Wilson

CEO Approval Rating

90/100

Read more